Johnson & Johnson Vision is presenting a broad range of new clinical and preclinical data at the 2026 Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Denver, highlighting advancements across IOLs, contact lenses, and myopia management.

The company’s scientific program includes 17 posters and oral presentations, featuring innovations such as the recently FDA-approved Tecnis PureSee IOL and new research aimed at improving visual outcomes across a range of patient needs.

· Pre-clinical assessment of combined tilt and decentration impact on performance of EDF IOLs. State, Mihai (Poster presentation: May 7, 2:00PM - 3:45PM MT)

· Evaluation of distance image quality in intraocular lenses using natural images. Alarcon Heredia, Aixa et al. (Oral presentation: May 6, 3:30PM - 3:45PM MT)

The company also shared new insights into the role of peripheral optics in functional vision. Research showed that while current IOLs offer similar peripheral refractive performance, a potential next-generation peripheral vision IOL design could improve peripheral vision to levels comparable to natural eyes. This may translate into real-world benefits such as faster reaction times and improved hazard detection during activities like driving.

· In vitro evaluation and optical simulation of peripheral refractive errors in pseudophakic eyes. Romashchenko, Dmitry et al. (Poster presentation: May 7, 2:00PM – 3:45PM MT)

· New peripheral vision IOL: optical improvements to functional benefits. Del Aguila Carrasco, Antonio et al. (Poster presentation: May 7, 2:00PM – 3:45PM MT)

· Measurement of Peripheral Refractive Errors (PRE) in Pseudophakic Eyes with different IOL technologies comparing an autorefractor with an aberrometer. Barcala Gosende, Xoana et al. (Poster presentation: May 7, 2:00PM – 3:45PM MT)

· Relevance of Peripheral Vision and Reaction Time on Driving Performance. El Aissati, Sara et al. (Poster presentation: May 4, 11:15AM – 1:00PM MT)

In contact lens research, Johnson & Johnson introduced a new “moisture retention index” designed to quantify how well different lens materials resist evaporation. The metric, measured on a 0–100% scale, revealed significant variability among 20 commercially available materials, with potential implications for on-eye comfort and performance.

· Development of a Moisture Retention Index for Contact Lens Materials. Riederer, Donald et al. (Poster presentation: May 4, 11:15AM - 1:00PM MT)

The company also presented new findings in myopia management, including 24-month data on Acuvue Abiliti 1-Day lenses. The results showed reduced myopia progression in children compared with a real-world control group. Additional research examined optical performance of myopia control designs and confirmed favorable safety profiles for soft contact lens use in children, with lower rates of corneal infiltrative events observed in younger patients than in adults.

· 24-Month Myopia Progression for Chinese Children Wearing Abiliti™ 1-Day Contact Lenses and a Real-World Control. Nixon, Alex et al. (Poster presentation: May 3, 3:15PM – 5:00PM MT)

· Simulating the on-eye optical properties of two myopia control lens designs. Chen, Minghan et al. (Poster presentation: May 6, 2:00PM - 3:45PM MT)

· The Safety of Soft Contact Lens Wear in Children – A Systematic Review. Nti, Augustine et al. (Poster presentation: May 4, 11:15AM - 1:00PM MT)

Beyond these areas, Johnson & Johnson is also sharing research related to geographic atrophy, including real-world evidence and patient preference data.

More poster and oral presentations from Johnson & Johnson at the ARVO 2026 Annual Meeting can be found through the event Online Meeting Planner.